Lichen verrucosus et reticularis

From WikiMD's WELLNESSPEDIA


Lichen verrucosus et reticularis
Synonyms
Pronounce N/A
Specialty Dermatology
Symptoms Skin lesions, itching
Complications
Onset
Duration
Types N/A
Causes Unknown
Risks
Diagnosis Clinical diagnosis, skin biopsy
Differential diagnosis Lichen planus, Lichen simplex chronicus
Prevention N/A
Treatment Topical corticosteroids, antihistamines
Medication
Prognosis
Frequency Rare
Deaths N/A


Lichen verrucosus et reticularis is a rare dermatological condition characterized by the presence of hyperkeratotic papules and plaques, often with a reticular pattern. The condition is also known as Lichen verrucosus or Lichen reticularis.

Etiology[edit]

The exact cause of Lichen verrucosus et reticularis is unknown. However, it is believed to be an autoimmune disease, where the body's immune system mistakenly attacks healthy skin cells. Some researchers suggest that it may be triggered by an infection or exposure to certain chemicals or medications.

Symptoms[edit]

The primary symptom of Lichen verrucosus et reticularis is the appearance of rough, wart-like growths on the skin. These growths are typically skin-colored or slightly darker and may be arranged in a reticular (net-like) pattern. Other symptoms may include itching, discomfort, and in some cases, bleeding from the affected areas.

Diagnosis[edit]

Diagnosis of Lichen verrucosus et reticularis is primarily based on the clinical presentation of the skin lesions. A biopsy of the affected skin may be performed to confirm the diagnosis and rule out other conditions with similar symptoms, such as psoriasis or lichen planus.

Treatment[edit]

Treatment for Lichen verrucosus et reticularis is aimed at managing symptoms and preventing complications. This may include the use of topical corticosteroids to reduce inflammation and itching, and retinoids to slow the growth of skin cells. In severe cases, systemic medications or phototherapy may be recommended.

Prognosis[edit]

The prognosis for individuals with Lichen verrucosus et reticularis varies. While the condition is not life-threatening, it can cause significant discomfort and may impact quality of life. With appropriate treatment, symptoms can often be managed effectively.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.